PayerPrice
Data Platform
More
Check Local Rates

HCPCS J3403 (Encelto) Fee Schedule

Medicare rates as of January 2026

HCPCS J3403 is classified under Drugs Administered Other than Oral Method, in the Drugs, Administered by Injection subgroup.

Revakinagene taroretcel-lwey, per implant
Key FactDetail
Service Type

Drugs Administered Other than Oral Method

Drugs, Administered by Injection

Hospital Outpatient Group (APC)APC 897 - Revakinagene, per implant
Surgery Center Payment (ASC)K2 - Drug paid separately with a covered surgery, at the OPPS rate
Medicare Fee Schedule$265,000.00 per billing unit (January 2026 ASP)View Medicare rates for J3403
Medicaid Fee Schedule$262,233.77 median of the 8 states in the free previewView Medicaid rates for J3403
WAC Price
Lorem ipsum dolor sit amet consectetur Lorem ipsum dolor sit amet consectetur
Related NDC Codes

• 82958050101 - Encelto Imp


National average reimbursement for HCPCS J3403 by major payers:

BCBS / Anthem logo

$249,435.51

BCBS / Anthem

UnitedHealthcare logo

$265,000.00

UnitedHealthcare

Aetna logo

$513,136.09

Aetna

Cigna logo

$N/A

Cigna

Compare published rates across providers.

Choose a payer to see a sample of rates for HCPCS J3403.

HCPCS J3403

No sample rates available for this payer and code. Search provider rates to explore coverage.

Get a free rate benchmark for your specialty.

Choose your state and specialty to build a report from payer-published rates.

Looking for other data?

Use market rates to prepare your payer proposal.

Rate Benchmarking

Compare your rates with similar providers.

Select a published rate, define comparable providers, and see where that rate falls in your market.

See a sample rate comparison

Payer Contract Negotiation

Draft a fee schedule renegotiation letter.

Use your fee schedule and market benchmarks to set target rates and draft a letter for your payer.

See a sample payer proposal

HCPCS J3403 vs. Other Drugs, Administered by Injection Codes

The table lists codes related to J3403. Select one to see its fee schedule.

CodeDescription
82958050101-NDCEncelto Imp
J3403-HCPCSRevakinagene taroretcel-lwey, per implant

What is a fee schedule?

A fee schedule is a list of fixed prices that healthcare providers charge for specific services, including HCPCS J3403. These prices vary depending on payer type (Medicare, Medicaid, private insurance), geographic location, and provider contracts.

Understanding the J3403 fee schedule helps patients estimate costs and providers optimize billing for accurate reimbursements.

Factors that affect fee schedules


Medicare & Medicaid Rates

Government-set reimbursement amounts


Private Insurance Rates

Negotiated rates between providers and insurance companies


Geographic Location

Costs may be higher in urban areas.


Provider Type

Hospital providers may have different rates than private practice.

FREE SAMPLE MARKET COMPARISON

Let's review your payer contracts side-by-side with the market.

Bring your top codes (like HCPCS J3403) and we'll show you how you compare in 15 minutes or less.

Frequently Asked Questions

What APC is HCPCS J3403 assigned to?


Medicare's hospital outpatient payment system (OPPS) assigns HCPCS J3403 to APC 897 (Revakinagene, per implant). An APC groups outpatient services that Medicare pays at the same base rate.

How does Medicare pay for HCPCS J3403 in an ambulatory surgery center?


CMS lists HCPCS J3403 with ASC payment indicator K2: Drug paid separately with a covered surgery, at the OPPS rate.

Request a sample

Tell us what you want to see. We'll pull a sample and email it to you.

Add an NPI or Tax ID to match a specific provider.

Rather talk first? Pick a time